Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces that it has submitted a marketing authorization application (MAA) in Europe for TLX101-Px ...
Management to hold webcast today at 5:00 pm EasternNew York, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results